Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effect of aiTBS on Intrinsic Spectral Dynamics and Task Performance

NCT: NCT07565207 · NOT_YET_RECRUITING

NCT IDNCT07565207
StatusNOT_YET_RECRUITING
Start Date2026-06-01
Completion2030-05-30

Brief Summary

Aim 1: Measure local shifts in cortical spectral dynamics following aiTBS. Aim 2: Measure network-specific shifts in task performance following aiTBS. Exploratory aim: Evaluate changes to resting state spectral dynamics in absence of stimulation after aiTBS.

Frequently Asked Questions

What is Effect of aiTBS on Intrinsic Spectral Dynamics and Task Performance?

Effect of aiTBS on Intrinsic Spectral Dynamics and Task Performance is a clinical trial registered under NCT07565207. Current status: NOT_YET_RECRUITING.

What is the status of NCT07565207?

The current status of NCT07565207 (Effect of aiTBS on Intrinsic Spectral Dynamics and Task Performance) is: NOT_YET_RECRUITING.

When did Effect of aiTBS on Intrinsic Spectral Dynamics and Task Performance start?

Effect of aiTBS on Intrinsic Spectral Dynamics and Task Performance started on 2026-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑